2021
DOI: 10.3390/vaccines9111351
|View full text |Cite|
|
Sign up to set email alerts
|

Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development

Abstract: Vaccines have been developed at “warp speed” to combat the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus. Although they are considered the best approach for preventing mortality, when assessing the safety of these vaccines, pregnant women have not been included in clinical trials. Thus, vaccine safety for this demographic, as well as for the developing fetus and neonate, remains to be determined. A global effort has been underway to encourage pregnant women to get vaccinated despite the uncertain risk… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 153 publications
0
4
0
1
Order By: Relevance
“…Furthermore, risk estimates would have moved toward null because of the potential disadvantages of viral vector vaccines. 29 Given that uncertainties remain regarding the timing of pregnancy loss and bias determination from the self-selection of vaccinated groups, more reproducible methodologies to assess vaccination safety during pregnancy would need to be developed.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, risk estimates would have moved toward null because of the potential disadvantages of viral vector vaccines. 29 Given that uncertainties remain regarding the timing of pregnancy loss and bias determination from the self-selection of vaccinated groups, more reproducible methodologies to assess vaccination safety during pregnancy would need to be developed.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, spontaneous abortions and stillbirths could be expected when the mother has been vaccinated 258,278 , either recently before or during pregnancy 279 . The movement of nutrient-rich HSA across the placental barrier is controlled by clathrin-enabled endocytosis.…”
Section: Endocrine Disorders Reproductive Health and Pregnancymentioning
confidence: 99%
“…The long-term outcomes are unknown. Karrow et al note that animal models suggest significant concerns for the use in pregnancy [62]. In their review of COVID-19 vaccine reactions in humans, they include among symptoms injection site erythema, pain, swelling, fatigue, headache, fever, and lymphadenopathy.…”
Section: Let's Work Together To Change Coursementioning
confidence: 99%
“…vaccines that are believed to contribute to adverse reactions, and which may negatively impact fetal and neonatal development [62].…”
Section: Let's Work Together To Change Coursementioning
confidence: 99%